Factor | Callens_2015_MicrDrugResi (10258)

Ceftiofur Use

Swine | Piglets

5

Description

Ceftiofur Use in Piglet

Resistance Outcomes

Resistance Microbe Outcome
Ceftiofur
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Ceftiofur Use 4.40 298
No Use 0.20 565
Ampicillin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Ceftiofur Use 52.40 298
No Use 33.60 655
Tetracycline
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Ceftiofur Use 34.20 298
No Use 28.90 565
Streptomycin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Ceftiofur Use 27.90 298
No Use 18.60 565
Sulfadiazine And Trimethoprim
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Ceftiofur Use 26.80 298
No Use 12.40 565